4Nakazawa M, Iizuka K, Ujiie A, et al. Research and development of ozagrel,a highly selective inhibitor of TXA2 synthase[J].Yakugaku Zasshi, 1994,114:911.
5Ishitsuka Y, Moriuchi H, Isohama Y, et al. A selective thromboxane a(2)(TXA(2)) synthase inhibitor, ozagrel, attenuates lung injury and decreases monocyte chemoattractant protein-1 and interleukin-8 mRNA expression in oleic acid-induced lung injury in guinea pigs. J Pharmacol Sci, 2009,111:211.
二级参考文献3
1Junichi A, Hiroshi M, Yasuji A, et al. Elevated plasma procogulant and Fibrinolytic markers in patients with chronic obstructive pulmonary disease. Internal Medicine,2002,41:181-183.
2Cordova C, Violi F, Alessandri C, et al. Improvement of blood gas levels after calcium-heparin treatment in patients with chronic obstructive pulmonary disease. Thromb Res ,1992,68:435-440.
